Oncology

Latest News

eye on pharma banner
Eye on Pharma: Celltrion Biosimilars Win Tenders; Oral Ustekinumab Device Passes Phase 1 Trial

February 12th 2024

Celltrion announced that 3 of its oncology biosimilar products have won tender contracts in France and Italy, and an experimental oral delivery device utilizing an ustekinumab biosimilar was successful in a phase 1 study.

syringes | Image credit: SOPONE - stock.adobe.com
Analyzing Safety of Switching From Originators to Biosimilars: A Meta-Analysis of 21 Trials

February 10th 2024

data | Image credit: apinan - stock.adobe.com
Vizient Report Emphasizes Biosimilar Successes, Impact of Inflation on Drug Spend

February 7th 2024

AI generated image for cost savings | Image credit: 1st footage - stock.adobe.com
Report: Varied Biosimilar Uptake Speeds Pose Missed Opportunities for Cost Savings

January 23rd 2024

doctor filling syringe | Image credit: natali_mis - stock.adobe.com
Postapproval Pharmacovigilance Review Confirms Comparable Safety Between Sandoz Biosimilars, Originators

January 20th 2024

Video Series
Video Interviews
Podcasts
CFB podcast banner
CFB podcast banner
CfB podcast banner
CfB podcast banner
CfB podcast banner
CfB podcast banner
CfB podcast banner
CfB podcast banner
CfB podcast banner
Latest CME Events & Activities

More News

© 2024 MJH Life Sciences

All rights reserved.